Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 2
1975 3
1976 4
1979 2
1980 4
1982 1
1983 2
1984 1
1989 1
1990 1
1991 1
1994 3
1995 4
1996 2
1997 4
1998 1
2000 5
2001 1
2002 5
2003 4
2004 5
2005 3
2006 4
2007 9
2008 9
2009 9
2010 15
2011 18
2012 15
2013 11
2014 23
2015 24
2016 29
2017 19
2018 19
2019 10
2020 8
2021 10
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Treatment of Ovarian Cancer.
Orr B, Edwards RP. Orr B, et al. Among authors: edwards rp. Hematol Oncol Clin North Am. 2018 Dec;32(6):943-964. doi: 10.1016/j.hoc.2018.07.010. Hematol Oncol Clin North Am. 2018. PMID: 30390767 Review.
Immunotherapy Advances for Epithelial Ovarian Cancer.
Hartnett EG, Knight J, Radolec M, Buckanovich RJ, Edwards RP, Vlad AM. Hartnett EG, et al. Among authors: edwards rp. Cancers (Basel). 2020 Dec 11;12(12):3733. doi: 10.3390/cancers12123733. Cancers (Basel). 2020. PMID: 33322601 Free PMC article. Review.
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression.
Pavicic PG Jr, Rayman PA, Swaidani S, Rupani A, Makarov V, Tannenbaum CS, Edwards RP, Vlad AM, Diaz-Montero CM, Mahdi H. Pavicic PG Jr, et al. Among authors: edwards rp. Oncoimmunology. 2023 Apr 10;12(1):2198185. doi: 10.1080/2162402X.2023.2198185. eCollection 2023. Oncoimmunology. 2023. PMID: 37066116 Free PMC article.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2; Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, Arnold N, Arun BK, Arver B, Ashworth A; Australian Ovarian Cancer Study Group; Baglietto L, Balleine R, Bandera EV, Barrowdale D, Bean YT, Beckmann L, Beckmann MW, Benitez J, Berger A, Berger R, Beuselinck B, Bisogna M, Bjorge L, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bolla MK, Bonanni B, Brand JS, Brauch H; Breast Cancer Family Register; Brenner H, Brinton L, Brooks-Wilson A, Bruinsma F, Brunet J, Brüning T, Budzilowska A, Bunker CH, Burwinkel B, Butzow R, Buys SS, Caligo MA, Campbell I, Carter J, Chang-Claude J, Chanock SJ, Claes KBM, Collée JM, Cook LS, Couch FJ, Cox A, Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F, Dansonka-Mieszkowska A, Darabi H, de la Hoya M, deFazio A, Dennis J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM, Dörk T, Silva IDS, du Bois A, Dumont M, Dunning AM, Duran M, Easton DF, Eccles D, Edwards RP See abstract for full author list ➔ Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, et al. Among authors: edwards rp. Gynecol Oncol. 2016 May;141(2):386-401. doi: 10.1016/j.ygyno.2015.04.034. Epub 2015 May 2. Gynecol Oncol. 2016. PMID: 25940428 Free PMC article. Review.
Human papillomavirus vaccine for cancer prevention.
Finn OJ, Edwards RP. Finn OJ, et al. Among authors: edwards rp. N Engl J Med. 2009 Nov 5;361(19):1899-901. doi: 10.1056/NEJMe0907480. N Engl J Med. 2009. PMID: 19890134 No abstract available.
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells.
Dong B, Obermajer N, Tsuji T, Matsuzaki J, Bonura C, Withers H, Long M, Chavel C, Olejniczak SH, Minderman H, Edwards RP, Storkus WJ, Romero P, Kalinski P. Dong B, et al. Among authors: edwards rp. Res Sq [Preprint]. 2023 Oct 19:rs.3.rs-3399211. doi: 10.21203/rs.3.rs-3399211/v1. Res Sq. 2023. PMID: 37886562 Free PMC article. Preprint.
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Brian Szender J, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, Cramer D, Doherty JA, Edwards RP, Fridley BL, Goode EL, Goodman MT, Hogdall E, Hosono S, Jensen A, Jordan S; Australian Ovarian Cancer Study Group; Kjaer SK, Matsuo K, Ness RB, Olsen CM, Olson SH, Leigh Pearce C, Pike MC, Anne Rossing M, Szamreta EA, Thompson PJ, Tseng CC, Vierkant RA, Webb PM, Wentzensen N, Wicklund KG, Winham SJ, Wu AH, Modugno F, Schildkraut JM, Terry KL, Kelemen LE, Moysich KB. Cannioto R, et al. Among authors: edwards rp. Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1114-24. doi: 10.1158/1055-9965.EPI-15-1330. Epub 2016 May 6. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 27197285 Free PMC article. Review.
273 results